GenSpera strengthens intellectual property for second prostate cancer drug
添加时间:2011-04-07 原文发表:2011-03-17 人气:3
GenSpera, Inc. (OTC.BB: GNSZ) announced that its patent application, entitled Activation of Peptide Prodrugs by HK2, has been issued by the United States Patent and Trademark Office (USPTO) as US Patent 7,906,477. The patent covers the...